The Tobacco Regulatory Science Program (TRSP) is an interagency partnership between the NIH and the FDA Center for Tobacco Products to foster tobacco regulatory research.
With the passage of the 2009 Family Smoking Prevention and Tobacco Control Act (Tobacco Control Act), the FDA acquired the authority to regulate the manufacture, marketing, and distribution of tobacco products in order to protect public health. Within the framework of the Tobacco Control Act, the NIH and FDA formed this partnership to establish a comprehensive research agenda in tobacco regulatory science.
Current K, R01, and R21 funding announcements for career development awards, secondary analysis of existing datasets and biospecimens, and pharmacokinetics of tobacco products. Frequently asked questions and recorded pre-application webinars are available for select funding opportunities.
TRSP encourages research applications that address the FDA's research priorities to better understand toxicity, addiction, and appeal of tobacco products.
In March 2020, the U.S. Food and Drug Administration issued a final rule to require new health warnings on cigarette packages and in cigarette advertisements with photo-realistic color images depicting some of the lesser-known, but serious health risks of cigarette smoking.
The final rule was set to go into effect on June 18, 2021. However, due to disruptions caused by the COVID-19 pandemic, the effective date has been postponed to October 16, 2021.
An NIH-FDA partnership to foster tobacco regulatory research.
Research projects on tobacco regulatory research funded through TRSP.
Active funding announcements and application information.
Research topic and project priorities for TRSP funding announcements.
Research tools, publications, statistics, and announcements.